Cargando…
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells
BACKGROUND: Immunoactivation is less evident in secondary progressive MS (SPMS) compared to relapsing-remitting disease. MicroRNA (miRNA) expression is integral to the regulation of gene expression; determining their impact on immune-related cell functions, especially CD4+ T cells, during disease pr...
Autores principales: | Sanders, Katherine A., Benton, Miles C., Lea, Rod A., Maltby, Vicki E., Agland, Susan, Griffin, Nathan, Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002332/ https://www.ncbi.nlm.nih.gov/pubmed/27570566 http://dx.doi.org/10.1186/s13148-016-0253-y |
Ejemplares similares
-
Genome-wide DNA methylation changes in CD19(+) B cells from relapsing-remitting multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2018) -
Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2015) -
Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
por: Groen, Kira, et al.
Publicado: (2020) -
Erythrocytes in multiple sclerosis – forgotten contributors to the
pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016) -
Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis
por: Groen, Kira, et al.
Publicado: (2018)